01-671-942

beta Lactamase Monoclonal Antibody (8A5.A10), Invitrogen™

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 01-671-942-Each-of-1 In Stock ₹ 53,578.00

01-671-942 - Each of 1

₹ 53,578.00

In Stock

Quantity

1

Base Price: ₹ 53,578.00

GST (18%): ₹ 9,644.04

Total Price: ₹ 63,222.04

Antigen

beta Lactamase

Classification

Monoclonal

Concentration

1.6 mg/mL

Formulation

PBS with no preservative; pH 7.4

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Western Blot

Clone

8A5.A10

Conjugate

Unconjugated

Gene Alias

blaCTX-M-14; FLJ14902; G24; lactamase beta; LACTB; mitochondrial 39S ribosomal protein L56; MRPL56; Serine beta-lactamase-like protein LACTB, mitochondrial; UNQ843/PRO1781

Immunogen

5'-His-tagged TEM-1 beta-lactamase.

Quantity

500 μg

Primary or Secondary

Primary

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Fischer Scientific

01-671-943

--

Img

Fischer Scientific

01-671-880

--

Img

Fischer Scientific

01-671-884

--

Img

Fischer Scientific

01-671-925

--

Img

Fischer Scientific

01-671-927

--

Img

Fischer Scientific

01-671-901

--

Img

Fischer Scientific

01-671-997

--

Img

Fischer Scientific

01-671-999

--

Description

  • MA1-10712 detects beta Lactamase from E
  • coli samples
  • MA1-10712 has been successfully used in ELISA and Western blot applications
  • The MA1-10712 immunogen is 5-His-tagged TEM-1 beta-lactamase
  • The beta lactam antibiotics (penicillins and cephalosporins) are the most frequently used antimicrobial agents
  • All of the beta lactams are structurally related through the presence of a core beta lactam ring
  • Bacterial resistance to beta lactams continues to increase, primarily due to the production of beta lactamases
  • Beta lactamases catalyze the hydrolysis of the beta lactam bond, which destroys antibacterial activity
  • Bacteria that produce TEM type or SHV type beta lactamases have point mutations in structural genes that have extended the substrate specificity of these beta lactamases
  • As a result, many of the beta lactamase producing Gram negative pathogens have become multidrug resistant.